Breaking News

Delpharm Sets Sights on Major Expansion

Enters negotiations with Famar for the acquisition of five manufacturing sites in France and abroad.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Delpharm and Famar, European leaders in contract manufacturing and development of medicines for pharmaceutical laboratories, have entered into exclusive negotiations for the acquisition by Delpharm of 5 Famar manufacturing sites in France, the Netherlands and Canada.   The transaction involves the takeover of the French sites located in Orléans (Loiret), Aigle (Orne) and St-Rémy-sur-Avre (Eure-et-Loire), the Pointe-Claire site in Quebec, and that of Bladel in the Netherlands. The group of 5 site...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters